| Use of normal tissue complication probability models in the clinic LB Marks, ED Yorke, A Jackson, RK Ten Haken, LS Constine, A Eisbruch, ... International Journal of Radiation Oncology* Biology* Physics 76 (3), S10-S19, 2010 | 1878 | 2010 |
| Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues SM Bentzen, LS Constine, JO Deasy, A Eisbruch, A Jackson, LB Marks, ... International Journal of Radiation Oncology* Biology* Physics 76 (3), S3-S9, 2010 | 1189 | 2010 |
| Radiation dose-volume effects in the lung LB Marks, SM Bentzen, JO Deasy, FMS Kong, JD Bradley, IS Vogelius, ... International Journal of Radiation Oncology* Biology* Physics 76 (3), S70-S76, 2010 | 1134 | 2010 |
| The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial YJR Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bentzen SM ... Lancet 371 (9618), 1098-1107, 2008 | 1106* | 2008 |
| Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology SM Bentzen Nature Reviews Cancer 6 (9), 702-713, 2006 | 1087 | 2006 |
| Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study M Nordsmark, SM Bentzen, V Rudat, D Brizel, E Lartigau, P Stadler, ... Radiotherapy and Oncology 77 (1), 18-24, 2005 | 1082 | 2005 |
| Overgaard J (2005) Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study M Nordsmark, SM Bentzen, V Rudat, D Brizel, E Lartigau, P Stadler, ... Radiother Oncol 77, 18-24, 0 | 1082* | |
| The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial TS Trialists' Group The lancet oncology 9 (4), 331, 2008 | 1042 | 2008 |
| Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial PD Brown, S Pugh, NN Laack, JS Wefel, D Khuntia, C Meyers, A Choucair, ... Neuro-oncology 15 (10), 1429-1437, 2013 | 809 | 2013 |
| Radiation oncology in the era of precision medicine M Baumann, M Krause, J Overgaard, J Debus, SM Bentzen, J Daartz, ... Nature Reviews Cancer 16 (4), 234-249, 2016 | 717 | 2016 |
| Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial JR Owen, A Ashton, JM Bliss, J Homewood, C Harper, J Hanson, ... The lancet oncology 7 (6), 467-471, 2006 | 707 | 2006 |
| Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma J Overgaard, SM Bentzen, DG Gonzalez, M Hulshof, G Arcangeli, O Dahl, ... The Lancet 345 (8949), 540-543, 1995 | 707 | 1995 |
| Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial J Yarnold, A Ashton, J Bliss, J Homewood, C Harper, J Hanson, ... Radiotherapy and oncology 75 (1), 9-17, 2005 | 601 | 2005 |
| Theragnostic imaging for radiation oncology: dose-painting by numbers SM Bentzen The lancet oncology 6 (2), 112-117, 2005 | 494 | 2005 |
| Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline BD Smith, SM Bentzen, CR Correa, CA Hahn, PH Hardenbergh, GS Ibbott, ... International Journal of Radiation Oncology* Biology* Physics, 2010 | 478 | 2010 |
| Time-dose factors in radiotherapy: a review of the human data HD Thames, SM Bentzen, I Turesson, M Overgaard, W Van den Bogaert Radiotherapy and Oncology 19 (3), 219-235, 1990 | 475 | 1990 |
| Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer D De Ruysscher, M Pijls-Johannesma, SM Bentzen, A Minken, ... Journal of clinical oncology 24 (7), 1057-1063, 2006 | 403 | 2006 |
| Reproducibility of dynamic contrast‐enhanced MRI in human muscle and tumours: comparison of quantitative and semi‐quantitative analysis SM Galbraith, MA Lodge, NJ Taylor, GJS Rustin, S Bentzen, JJ Stirling, ... NMR in Biomedicine 15 (2), 132-142, 2002 | 383 | 2002 |
| Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology J Overgaard, DG Gonzalez, M Hulshof, G Arcangeli, O Dahl, O Mella, ... International journal of hyperthermia 12 (1), 3-20, 1996 | 373 | 1996 |
| Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function J Li, SM Bentzen, M Renschler, MP Mehta Journal of clinical oncology 25 (10), 1260-1266, 2007 | 368 | 2007 |
Ivan VogeliusClinical Professor at Dept. of Oncology, Rigshospitalet & Faculty of Health Sciences, CopenhagenVerified email at regionh.dk
